Trials / Recruiting
RecruitingNCT06924125
Spanish Natural History Study for LAMA2 Muscular Dystrophy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
- Sex
- All
- Age
- 0 Minutes – 100 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this natural history study is to comprehensively characterize the disease progression and clinical features of LAMA2-related dystrophies (LAMA2-RD) in the pediatric population. The study aims to establish a well-defined cohort of patients in Spain, enabling long-term follow-up and facilitating recruitment for future clinical trials.
Conditions
- LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
- Merosin Deficient CMD (Full or Partial)
- Merosin Deficient Congenital Muscular Dystrophy
- Muscular Dystrophies
- Cohort Studies
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Motor function scales | Evaluation of patients motor function using motor scales (MFM32, CHOP) |
| DIAGNOSTIC_TEST | MUSCLE ULTRASOUND | Ultrasound guided evaluation of 28 muscles evaluated accross different body regions, assessed using the Heckmatt gradinf system (semiquantitative scale). |
| DIAGNOSTIC_TEST | Muscle Elastography | Assess the mechanical properties of muscles, such as stiffness and elasticity. |
| OTHER | Complete physical examination | Complete physical evaluations including muscle power and goniometry measurements |
| OTHER | Ventilatory/ respiratory and other support assessment | Assessment of ventilatory, respiratory, and other support needs to evaluate the necessity of assistive devices |
| OTHER | Oromotor function and nutrition | Assessment of bulbar funcionality: feeding devices, nutritional status. |
| OTHER | Motor Milestone Assessments | Motor milestones age of acquisition and loss |
Timeline
- Start date
- 2021-07-27
- Primary completion
- 2030-07-01
- Completion
- 2030-07-01
- First posted
- 2025-04-11
- Last updated
- 2025-04-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06924125. Inclusion in this directory is not an endorsement.